| Clasificación | Nombre de la clínica | Valoración del paciente | País | Médico principal | experiencia | Técnicas | Mejor para | Por qué está clasificado | Acreditaciones |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 5.0 / 5 (2) | Gurgaon, India | — | — | — | — | — | Indian National Hospital Accreditation Board | |
| #2 | 4.0 / 5 (7) | Chennai, India | 18,000+ tratamientos | — | — | — | Indian National Accreditation Board for Testing and Calibration Laboratories, Indian National Hospital Accreditation Board | ||
| #3 | 4.6 / 5 (32) | Delhi, India | — | — | — | — | — | Joint Commission International , Indian National Accreditation Board for Testing and Calibration Laboratories | |
| #4 | 4.8 / 5 | Mumbai, India | — | — | — | — | Indian National Hospital Accreditation Board | ||
| #5 | 4.7 / 5 (7) | Panaji, India | — | — | — | — | — | Indian National Hospital Accreditation Board | |
| #6 | — / 5 | Chennai, India | — | — | — | — | — | — | |
| #7 | 4.9 / 5 | Delhi, India | — | — | Protocolo SCOTS, terapia con exosomas | Atrofia óptica dominante con protocolo SCOTS | El protocolo SCOTS registrado en los NIH utiliza células madre de médula ósea o cordón umbilical. Las células son procesadas en un laboratorio certificado por las normas GMP. Se ha tratado a más de 10,000 pacientes de 65 países. | Joint Commission International , ISO 9001:2015 Quality management systems |